Select Publications
Book Chapters
2024, 'Clinical/Cardiovascular/Cardiopulmonary Bypass: Effect of Alteration in Pump Speed on Pump Output and Left Ventricular Filling with Continuous-Flow Left Ventricular Assist Device', in American Society for Artificial Internal Organs (ASAIO) Platinum 70th Anniversary Special Edition, CRC Press, pp. 238 - 242, http://dx.doi.org/10.1201/9781003543480-37
,2008, 'Clinical Governance', in Advanced Renal Care, pp. 216 - 230, http://dx.doi.org/10.1002/9780470693995.ch15
,2008, 'Combination therapy for pulmonary arterial hypertension', in Pulmonary Arterial Hypertension, John Wiley & Sons Ltd, pp. 127 - 145
,2001, 'Right heart catheterisation and haemodynamic evaluation of the heart transplant patient', in Cardiology and cardiac catheterisation: the essential guide, Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 295 - 302
,1997, 'Cardiac transplantation', in Thompson P (ed.), Coronary Care Manual, Churchill Livingstone, New York NY, pp. 403 - 405
,1991, 'Cardiac transplantation: Australian results', in Artificial Heart 3, Springer Japan, pp. 257 - 262, http://dx.doi.org/10.1007/978-4-431-68126-7_30
,Journal articles
2024, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, 30, pp. 1481 - 1486, http://dx.doi.org/10.1177/1357633X231151714
,2024, 'Cost-Effectiveness of Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation in the Australian Health Care System', Heart Lung and Circulation, 33, pp. 1173 - 1183, http://dx.doi.org/10.1016/j.hlc.2024.03.004
,2024, 'Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial', The Lancet Respiratory Medicine, 12, pp. 523 - 534, http://dx.doi.org/10.1016/S2213-2600(24)00072-9
,2024, 'Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy', Chest, 165, pp. 967 - 977, http://dx.doi.org/10.1016/j.chest.2023.10.037
,2024, 'Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension', Advances in Therapy, 41, pp. 1062 - 1074, http://dx.doi.org/10.1007/s12325-023-02769-7
,2024, 'Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients', Transplantation, http://dx.doi.org/10.1097/TP.0000000000005131
,2024, 'Meta-analysis and systematic review of gout prevalence in the heart/lung transplantation population', Frontiers in Transplantation, 3, http://dx.doi.org/10.3389/frtra.2024.1356058
,2024, 'Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S106 - S106, http://dx.doi.org/10.1016/j.healun.2024.02.213
,2023, 'Orthotopic Heart Transplantation Followed By Autologous Stem Cell Transplantation in Patients with Cardiac AL Amyloidosis: Results from a Single Centre Prospective Study', Blood, 142, pp. 3414 - 3414, http://dx.doi.org/10.1182/blood-2023-184319
,2023, 'DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and Phenocopies', Circulation: Genomic and Precision Medicine, 16, pp. 421 - 430, http://dx.doi.org/10.1161/CIRCGEN.123.004221
,2023, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation', ESC Heart Failure, 10, pp. 1980 - 1986, http://dx.doi.org/10.1002/ehf2.14226
,2023, 'Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?', Transplantation, 107, pp. 1390 - 1397, http://dx.doi.org/10.1097/TP.0000000000004511
,2023, 'Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing', Heart Lung and Circulation, 32, pp. 156 - 165, http://dx.doi.org/10.1016/j.hlc.2022.09.005
,2023, 'Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases', Transplantation, 107, pp. 361 - 371, http://dx.doi.org/10.1097/TP.0000000000004294
,2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057
,2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095
,2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122
,2022, 'Pulmonary haemodynamics and pulmonary congestion: where are we now?', European Heart Journal, 43, pp. 4515, http://dx.doi.org/10.1093/eurheartj/ehac499
,2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830, http://dx.doi.org/10.1111/imj.15926
,2022, 'Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary Arteries', Heart Lung and Circulation, 31, pp. 1185 - 1187, http://dx.doi.org/10.1016/j.hlc.2022.07.010
,2022, 'Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation', Circulation, 145, pp. 1811 - 1824, http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057006
,2022, 'Impact of frailty on mortality and morbidity in bridge to transplant recipients of contemporary durable mechanical circulatory support', Journal of Heart and Lung Transplantation, 41, pp. 829 - 839, http://dx.doi.org/10.1016/j.healun.2022.02.008
,2022, 'Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort', Journal of Heart and Lung Transplantation, 41, pp. 445 - 457, http://dx.doi.org/10.1016/j.healun.2021.11.004
,2022, 'Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease', Biophysical Reviews, 14, pp. 369 - 379, http://dx.doi.org/10.1007/s12551-022-00930-0
,2022, 'Validation of Cognitive Impairment in Combination with Physical Frailty as a Predictor of Mortality in Patients with Advanced Heart Failure Referred for Heart Transplantation', Transplantation, 106, pp. 200 - 209, http://dx.doi.org/10.1097/TP.0000000000003669
,2022, 'Impact of Initial Therapeutic Strategy on Long-Term Outcomes in Pulmonary Arterial Hypertension: An Analysis of the PHSANZ Registry', Heart, Lung and Circulation, 31, pp. S86 - S86, http://dx.doi.org/10.1016/j.hlc.2022.06.095
,2021, 'Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry', Respirology, 26, pp. 1171 - 1180, http://dx.doi.org/10.1111/resp.14162
,2021, 'Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension', EUROPEAN HEART JOURNAL, 42, pp. 1958 - 1958, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720456902159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies', Journal of Heart and Lung Transplantation, 40, pp. 841 - 849, http://dx.doi.org/10.1016/j.healun.2021.04.005
,2021, 'Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study', Journal of Heart and Lung Transplantation, 40, pp. 494 - 503, http://dx.doi.org/10.1016/j.healun.2021.02.006
,2021, 'Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study)', JACC: Heart Failure, 9, pp. 301 - 313, http://dx.doi.org/10.1016/j.jchf.2021.01.007
,2021, 'Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry', Respiratory Medicine, 178, http://dx.doi.org/10.1016/j.rmed.2020.106220
,2021, 'The impact of frailty on mortality after heart transplantation', Journal of Heart and Lung Transplantation, 40, pp. 87 - 94, http://dx.doi.org/10.1016/j.healun.2020.11.007
,2020, 'Abstract 14268: Responses to Exercise During Right Heart Catheterisation in Pulmonary Hypertension', Circulation, 142, http://dx.doi.org/10.1161/circ.142.suppl_3.14268
,2020, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post cardiac transplantation but PVR is a prognostic tool in LVAD-bridged patients', European Heart Journal, 41, http://dx.doi.org/10.1093/ehjci/ehaa946.2228
,2020, 'Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges', Heart Lung and Circulation, 29, pp. 1459 - 1468, http://dx.doi.org/10.1016/j.hlc.2020.01.017
,2020, 'Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry', Respirology, 25, pp. 863 - 871, http://dx.doi.org/10.1111/resp.13768
,2020, 'In Honour of Professor Cristobal dos Remedios on behalf of the MAWA Trust', Biophysical Reviews, 12, pp. 765 - 766, http://dx.doi.org/10.1007/s12551-020-00746-w
,2020, 'Pulmonary arterial hypertension with below threshold pulmonary vascular resistance', European Respiratory Journal, 56, http://dx.doi.org/10.1183/13993003.01654-2019
,2020, 'Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial', American Journal of Respiratory and Critical Care Medicine, 201, pp. 707 - 717, http://dx.doi.org/10.1164/rccm.201908-1640OC
,2020, 'Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics', Pulmonary Circulation, 10, http://dx.doi.org/10.1177/2045894019866335
,2020, 'Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort', Chest, 157, pp. 162 - 172, http://dx.doi.org/10.1016/j.chest.2019.08.2203
,2020, '063 A Case of Chronic Thromboembolic Pulmonary Hypertension in a Heart Transplant Patient, Successfully Treated With Pulmonary Endarterectomy', Heart, Lung and Circulation, 29, pp. S65 - S65, http://dx.doi.org/10.1016/j.hlc.2020.09.070
,2020, '158 Reconsidering the Threshold: Should Pulmonary Vascular Resistance >2 Wood Units be Considered Pulmonary Hypertension?', Heart, Lung and Circulation, 29, pp. S106 - S106, http://dx.doi.org/10.1016/j.hlc.2020.09.165
,